Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-2053Fax+1 617-632-4970
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
- Tufts Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of North Carolina at Chapel Hill School of MedicineClass of 1999
Certifications & Licensure
- MA State Medical License 2002 - 2026
- RI State Medical License 2005 - 2018
Clinical Trials
- Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma Start of enrollment: 2013 Mar 01
- Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Start of enrollment: 2013 May 01
- Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial Start of enrollment: 2019 Jan 18
Publications & Presentations
PubMed
- 106 citationsReconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative NeoplasmsDebra Van Egeren, Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly
Cell Stem Cell. 2021-03-04 - 156 citationsCryopreservation of hematopoietic stem cells.David Berz, Elise M. McCormack, Eric S. Winer, Gerald A. Colvin, Peter J. Quesenberry
American Journal of Hematology. 2007-06-01 - 46 citationsPrognosis in primary effusion lymphoma is associated with the number of body cavities involved.Jorge J. Castillo, Helen Shum, Majid Lahijani, Eric S. Winer, James N. Butera
Leukemia & Lymphoma. 2012-05-16
Abstracts/Posters
- First Line Chemo-Free Therapy with the BRAF Inhibitor Vemurafenib Combined with Obinutuzumab Is Effective in Patients with HclEric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic LeukemiaEric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute LeukemiaEric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Is a Revolution in Cancer Treatment Within Reach?June 17th, 2023
- Cancer Treatment: Encouraging Signs Keep EmergingJune 25th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: